Obatoclax mesylate (GX15-070)

Obatoclax mesylate (GX15-070)

Catalog Number:
L002369086APE
Mfr. No.:
APE-A4194
Price:
$238
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          Obatoclax mesylate, also known as GX15-070, is a hydrophobic small molecule that potently inhibits BCL-2 family by binding to the BH3-binding site of BCL-2 and other related BCL-2 family members (including BCL-XL, MCL-1, A1, and BCL-B). As a pan-BCL-2 inhibitor being investigated for the treatment of refractory malignancies, obatoclax mesylate directly induce apoptosis in cultured acute myeloid leukemia (AML) cells as well as primary patient samples and exhibits antitumor activity in mouse xengografts of solid tumor and myeloma cell lines. Study results have shown that obatoclax mesylate inhibited clonogenic growth of primary AML samples (IC50 < nmol/L) and dissociated Bak and Bim from MCL-1 in cultured AML cells.

      • Properties
        • Alternative Name
          (2Z)-2-[(5Z)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxypyrrol-2-ylidene]indole;methanesulfonic acid
          CAS Number
          803712-79-0
          Molecular Formula
          C20H19N3O·CH4O3S
          Molecular Weight
          413.5
          Appearance
          A solid
          Purity
          98.49%
          Solubility
          insoluble in H2O; ≥20.7 mg/mL in DMSO; ≥3.15 mg/mL in EtOH with gentle warming and ultrasonic
          Storage
          Store at -20°C

          * For Research Use Only

      • Reference
        • 1. Xiang XY, Kang JS, et al. "SIRT3 participates in glucose metabolism interruption and apoptosis induced by BH3 mimetic S1 in ovarian cancer cells." Int J Oncol. 2016 Aug;49(2):773-84. PMID:27277143

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.